GlassScriptPhysician profile
Jacquelyn Coccia
NPI 1679282115
$1,106.77
in general payments reported to CMS, 2019-2025
16 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $635 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $339.79 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $144.46 | 2024 | Arcalyst |
| Amgen INC. | $121.21 | 2024-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.47 | 2024-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $77.19 | 2024 | Assure Wcd |
| Scpharmaceuticals INC. | $54.46 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $52.60 | 2024 | Farxiga, Wainua |
| Novo Nordisk INC | $52.32 | 2025 | Wegovy |
| Pfizer INC. | $45.78 | 2024-2025 | |
| Inspire Medical Systems, INC. | $26.74 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $23.44 | 2025 | Amvuttra |
| Edwards Lifesciences Corporation | $23.17 | 2025 | |
| Cvrx, INC. | $16.93 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $15.12 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.18 | 2024 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $13.91 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Coccia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.